Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trientine for cardiac dysfunction and left ventricular hypertrophy in adults with type 2 diabetes mellitus
ACTRN12609000053224Phase 2Completed
- Sponsor
- Protemix
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Trientine with Placebo (2 arms). Primary endpoints: Left ventricle mass indexed to body surface area, Early mitral annular velocity and 1 more. Started Mar 2001; status: completed.
02
Drugs
trientine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12609000053224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000053224.